Disruption of BIRC3 associates with Fludarabine Chemorefractoriness in TP53 Wild Type Chronic Lymphocytic Leukemia

被引：0
|
作者：
Fangazio, Marco [1 ]
Rasi, Silvia [1 ]
Vaisitti, Tiziana [2 ,3 ]
Monti, Sara [1 ]
Cresta, Stefania [1 ]
Bruscaggin, Alessio [1 ]
Spina, Valeria [1 ]
Forconi, Francesco
Chiaretti, Sabina [4 ]
Guarini, Anna [4 ]
Deaglio, Silvia [2 ,3 ]
Foa, Robin [4 ]
Gaidano, Gianluca [1 ]
Rossi, Davide [1 ]
机构：
[1] Amedeo Avogadro Univ Eastern Piedmont, Dept Clin & Expt Med, Div Hematol, Novara, Italy
[2] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy
[3] Univ Turin, Human Genet Fdn, Turin, Italy
[4] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Div Hematol, Rome, Italy
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：216 / 216
页数：1
相关论文
共 50 条
  • [1] Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia
    Rossi, Davide
    Fangazio, Marco
    Rasi, Silvia
    Vaisitti, Tiziana
    Monti, Sara
    Cresta, Stefania
    Chiaretti, Sabina
    Del Giudice, Ilaria
    Fabbri, Giulia
    Bruscaggin, Alessio
    Spina, Valeria
    Deambrogi, Clara
    Marinelli, Marilisa
    Fama, Rosella
    Greco, Mariangela
    Daniele, Giulia
    Forconi, Francesco
    Gattei, Valter
    Bertoni, Francesco
    Deaglio, Silvia
    Pasqualucci, Laura
    Guarini, Anna
    Dalla-Favera, Riccardo
    Foa, Robin
    Gaidano, Gianluca
    BLOOD, 2012, 119 (12) : 2854 - 2862
  • [2] Analysis of BIRC3 disruption in patients with chronic lymphocytic leukemia: association with complex karyotypes and TP53 deletion.
    Galvano, Camila
    Krzywinski, Andrea
    Graciela Stanganelli, Carmen
    Silvana Cugliari, MarAa
    De Stefano, Giselda
    Melillo, Luciana
    Miodosky, Marcela
    Fernandez, Diego
    Penalba, Romina
    Zerga, Marta
    Slavutsky, Irma
    LEUKEMIA & LYMPHOMA, 2020, 61 : 53 - 55
  • [3] Telomere status in chronic lymphocytic leukemia with TP53 disruption
    Guieze, Romain
    Pages, Melanie
    Veronese, Lauren
    Combes, Patricia
    Lemal, Richard
    Gay-Bellile, Mathilde
    Chauvet, Martine
    Callanan, Mary
    Kwiatkowski, Fabrice
    Pereira, Bruno
    Vago, Philippe
    Bay, Jacques-Olivier
    Tournilhac, Olivier
    Tchirkov, Andrei
    ONCOTARGET, 2016, 7 (35) : 56976 - 56985
  • [4] Clinical Impact of Clonal and Subclonal TP53, SF3B1, BIRC3, and ATM Mutations in Chronic Lymphocytic Leukemia
    Nadeu, Ferran
    Delgado, Julio
    Royo, Cristina
    Bauman, Tycho
    Stankovic, Tatjana
    Pinyol, Magda
    Jares, Pedro
    Navarro, Alba
    Martin-Garcia, David
    Bea, Silvia
    Salaverria, Itziar
    Oldreive, Ceri
    Aymerich, Marta
    Suarez-Cisneros, Helena
    Rozman, Maria
    Villamor, Neus
    Colomer, Dolors
    Lopez-Guillermo, Armando
    Gonzalez, Marcos
    Alcoceba, Miguel
    Jose Terol, Maria
    Colado, Enrique
    Puente, Xose S.
    Lopez-Otin, Carlos
    Enjuanes, Anna
    Campo, Elias
    BLOOD, 2015, 126 (23)
  • [5] TP53 Disruption in Chronic Lymphocytic Leukemia Under Ibrutinib: More is Worse?
    Bomben, Riccardo
    Zucchetto, Antonella
    Gentile, Massimo
    Gattei, Valter
    CLINICAL CANCER RESEARCH, 2021, 27 (16) : 4462 - 4464
  • [6] TP53 Aberrations in Chronic Lymphocytic Leukemia
    Trbusek, Martin
    Malcikova, Jitka
    ADVANCES IN CHRONIC LYMPHOCYTIC LEUKEMIA, 2013, 792 : 109 - 131
  • [7] BIRC3 mutations in chronic lymphocytic leukemia - uncommon and unfavorable
    Tausch, Eugen
    Stilgenbauer, Stephan
    HAEMATOLOGICA, 2020, 105 (02) : 255 - 256
  • [8] Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
    Nadeu, Ferran
    Delgado, Julio
    Royo, Cristina
    Baumann, Tycho
    Stankovic, Tatjana
    Pinyol, Magda
    Jares, Pedro
    Navarro, Alba
    Martin-Garcia, David
    Bea, Silvia
    Salaverria, Itziar
    Oldreive, Ceri
    Aymerich, Marta
    Suarez-Cisneros, Helena
    Rozman, Maria
    Villamor, Neus
    Colomer, Dolors
    Lopez-Guillermo, Armando
    Gonzalez, Marcos
    Alcoceba, Miguel
    Jose Terol, Maria
    Colado, Enrique
    Puente, Xose S.
    Lopez-Otin, Carlos
    Enjuanes, Anna
    Campo, Elias
    BLOOD, 2016, 127 (17) : 2122 - 2130
  • [9] An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness
    Rigolin, Gian Matteo
    Formigaro, Luca
    Cavallari, Maurizio
    Quaglia, Francesca Maria
    Lista, Enrico
    Urso, Antonio
    Guardalben, Emanuele
    Martinelli, Sara
    Saccenti, Elena
    Bassi, Cristian
    Lupini, Laura
    Bardi, Maria Antonella
    Volta, Eleonora
    Tammiso, Elisa
    Melandri, Aurora
    Negrini, Massimo
    Cavazzini, Francesco
    Cuneo, Antonio
    ONCOTARGET, 2017, 8 (17) : 28008 - 28020
  • [10] TP53 MUTATIONS AND DEL17P13 PREDICT SIMILAR OUTCOME AND CHEMOREFRACTORINESS IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Rossi, D.
    Cerri, M.
    Forconi, F.
    Deambrogi, C.
    Sozzi, E.
    Cresta, S.
    Rasi, S.
    Tassi, M.
    De Paoli, L.
    Raspadori, D.
    Capello, D.
    Gattei, V
    Lauria, F.
    Gaidano, G.
    HAEMATOLOGICA, 2008, 93 : S91 - S92
12345